Correction to “A Pt(IV) Pro-drug Preferentially Targets Indoleamine-2,3-dioxygenase, Providing Enhanced Ovarian Cancer Immuno-Chemotherapy”
Details
The content you want is available to Zendy users.Already have an account? Click here. to sign in.
Details